Disease and treatment characteristics do not predict symptom occurrence profiles in oncology outpatients receiving chemotherapy
C Miaskowski, BA Cooper, M Melisko, LM Chen… - Cancer, 2014 - Wiley Online Library
BACKGROUND A large amount of interindividual variability exists in the occurrence of
symptoms in patients receiving chemotherapy (CTX). The purposes of the current study …
symptoms in patients receiving chemotherapy (CTX). The purposes of the current study …
Serotonin transporter polymorphism in major depressive disorder (MDD), psychiatric disorders, and in MDD in response to stressful life events: causes and treatment …
A Daniele, R Divella, A Paradiso, V Mattioli, F Romito… - In vivo, 2011 - iv.iiarjournals.org
A functional polymorphism in the promoter region of the 5-hidroxytryptamine transporter
gene (5-HTTLPR), alters its transcription. Short allele (SS) variation decreases the …
gene (5-HTTLPR), alters its transcription. Short allele (SS) variation decreases the …
Translational genomic research: the role of genetic polymorphisms in MBSR program among breast cancer survivors (MBSR [BC])
Genetic variations of breast cancer survivors (BCS) may contribute to level of residual
symptoms, such as depression, stress, fatigue, and cognitive impairment. The objective of …
symptoms, such as depression, stress, fatigue, and cognitive impairment. The objective of …
Translational genomic research: the association between genetic profiles and cognitive functioning or cardiac function among breast cancer survivors completing …
Introduction: Emerging evidence suggests that Chemotherapy (CT) treated breast cancer
survivors (BCS) who have “risk variants” in genes may be more susceptible to cognitive …
survivors (BCS) who have “risk variants” in genes may be more susceptible to cognitive …
Post-traumatic stress symptoms and serotonin transporter (5-HTTLPR) polymorphism in breast cancer patients
Introduction: Post-traumatic Symptoms (PTSS) and Post-traumatic Stress Disorder (PTSD)
have been reported to affect a quite significant proportion of cancer patients. No study has …
have been reported to affect a quite significant proportion of cancer patients. No study has …
Examining the effect of 5-HTTLPR on depressive symptoms in postmenopausal women 1 year after initial breast cancer treatment
JS Wang, YP Conley, SM Sereika, CM Bender… - Supportive Care in …, 2019 - Springer
Background Depression following the diagnosis of breast cancer has been well
documented, and occurs in as many as 40% of women. The serotonin transporter gene …
documented, and occurs in as many as 40% of women. The serotonin transporter gene …
Genetic polymorphisms and haplotypes of ERCC1 and ERCC2 associated with quality of life, depression, and anxiety status among patients with lung cancer
Y Tang, R Zhang, Y Li, S Xu, H Wang, J Xu, L Xiao… - BMC cancer, 2021 - Springer
Background Patients with lung cancer (LC) have a poor quality of life (QoL) and easily suffer
from psychological diseases. Previous studies focused less on the relationship between …
from psychological diseases. Previous studies focused less on the relationship between …
[PDF][PDF] Translational Genomic Research: The Association between Genetic Profiles and Cognitive Functioning or Cardiac Function Among Breast Cancer Survivors …
RR Reich, JW MS, L Gordillo-Casero, TW BS, AJ CIP… - 2022 - brittanybutts.com
Introduction: Emerging evidence suggests that Chemotherapy (CT) treated breast cancer
survivors (BCS) who have “risk variants” in genes may be more susceptible to cognitive …
survivors (BCS) who have “risk variants” in genes may be more susceptible to cognitive …
Facets of mindfulness in health professionals and patient adjustment to cancer
AK Sinclair - 2014 - era.ed.ac.uk
Systematic Review: Healthcare professionals work in highly emotive environments and are
considered to be at high risk of developing burnout due to the nature of their roles. There …
considered to be at high risk of developing burnout due to the nature of their roles. There …
Examining the effect of tumor features, BDNF, and 5-HTT genotypes on depressive symptoms in breast cancer
J Wang - 2019 - d-scholarship.pitt.edu
The development of depressive symptoms in women with breast cancer is multifactorial and
may be impacted by both genetics and pathologic tumor features. The purpose of this study …
may be impacted by both genetics and pathologic tumor features. The purpose of this study …